Literature DB >> 18926809

Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.

Indra Bachtiar1, Julian Mulya Santoso, Benny Atmanegara, Rino Alvani Gani, Irsan Hasan, Laurentius Adrianto Lesmana, Ali Sulaiman, Jianren Gu, Susan Tai.   

Abstract

BACKGROUND: To evaluate the diagnostic value of alpha-1-acid glycoprotein (AAG) and the combination with alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC) patients.
METHODS: AAG was measured in serum of 65 HCC patients and 54 chronic liver diseases (CLD) patients by using proteomic approach. Sensitivity and specificity of AAG and its combination with AFP were determined and compared with AFP alone for the diagnosis of HCC.
RESULTS: The expression concentration of AAG was significantly higher in HCC patients than chronic liver disease with sensitivity (77%) and accuracy (83%). Receiver operating characteristic analysis yielded the following AUC: AFP 0.750 (CI 95% 0.663-0.837), AAG 0.907 (CI 95% 0.855-0.960) and AFP+AAG 0.943 (CI 95% 0.897-0.988). At a specificity of 90%, the combination of AFP+AAG had sensitivity 89% and accuracy 90%, which was higher than sensitivity (52.3%) and accuracy (70%) when using AFP alone.
CONCLUSION: The combination of AAG and AFP shows high sensitivity and improves the accuracy of HCC diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926809     DOI: 10.1016/j.cca.2008.09.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.

Authors:  Hatem A El-mezayen; Hossam Darwish
Journal:  Tumour Biol       Date:  2014-04-01

2.  Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.

Authors:  Hui Zhou; Jun-Ming Guo; Yan-Ru Lou; Xin-Jun Zhang; Fa-De Zhong; Zhen Jiang; Jia Cheng; Bing-Xiu Xiao
Journal:  J Mol Med (Berl)       Date:  2010-03-28       Impact factor: 4.599

3.  Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.

Authors:  Ju Yeon Lee; Jin Young Kim; Gun Wook Park; Mi Hee Cheon; Kyung-Hoon Kwon; Yeong Hee Ahn; Myeong Hee Moon; Hyoung-Joo Lee; Young Ki Paik; Jong Shin Yoo
Journal:  Mol Cell Proteomics       Date:  2011-09-22       Impact factor: 5.911

4.  Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children.

Authors:  Prasad Devarajan; Catherine D Krawczeski; Mai T Nguyen; Thelma Kathman; Zhu Wang; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2010-10       Impact factor: 8.860

5.  Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.

Authors:  Yuqiu Ge; Bin Xu; Hongzhou Cai; Wentao Jing; Qiong Ouyang; Qinbo Yuan; Xu Li; Yuanming Fan; Yang Shen; Qianqian Shi; Qiangdong Wang; Li Cui; Xiaojian Yin; Gaoxiang Ma
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-05       Impact factor: 4.322

6.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

7.  Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma.

Authors:  Indra Bachtiar; Valentine Kheng; Gunawan A Wibowo; Rino A Gani; Irsan Hasan; Andri Sanityoso; Unggul Budhihusodo; Syafruddin Ar Lelosutan; Ruswhandi Martamala; Wenny A Achwan; Soewignyo Soemoharjo; Ali Sulaiman; Laurentius A Lesmana; Susan Tai
Journal:  BMC Res Notes       Date:  2010-11-23

8.  Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.

Authors:  Frank Tacke; Nicolas Kanig; Abdelaziz En-Nia; Thilo Kaehne; Christiane S Eberhardt; Victoria Shpacovitch; Christian Trautwein; Peter R Mertens
Journal:  BMC Cancer       Date:  2011-05-20       Impact factor: 4.430

9.  Orosomucoid in liver diseases.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

10.  Detection of differential levels of proteins in the urine of patients with endometrial cancer: analysis using two-dimensional gel electrophoresis and o-glycan binding lectin.

Authors:  Alan Kang-Wai Mu; Boon-Kiong Lim; Onn Haji Hashim; Adawiyah Suriza Shuib
Journal:  Int J Mol Sci       Date:  2012-07-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.